Liesbeth De Wever
KU Leuven, Universitair Ziekenhuis Leuven, St. Antonius Ziekenhuis
Papers
5
Total Citations
83
H-Index
4
About
Dr. Liesbeth De Wever is a leading researcher in urological oncology, with a focus on improving outcomes for prostate cancer patients through advanced imaging and surgical techniques. Her work centers on the integration of magnetic resonance imaging (MRI) into clinical decision-making, as demonstrated by her highly cited 2019 study on the impact of MRI on prostate cancer staging and risk classification (35 citations). Dr. De Wever’s most significant contribution is her pioneering investigation of the levator ani muscle’s role in urinary continence recovery after robot-assisted radical prostatectomy. Her multi-institutional 2022 study (18 citations) established that levator ani thickness is a key anatomical predictor of early continence, challenging the traditional focus on membranous urethral length. She has also addressed critical complications, such as severe arterial hemorrhage after prostatectomy, through her case series on endovascular management (17 citations). More recently, Dr. De Wever externally validated nomograms incorporating MRI features to predict side-specific extraprostatic extension (2023, 10 citations), further refining preoperative planning. Her research directly enhances patient quality of life and surgical precision, making her a vital contributor to evidence-based urological practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5